Ono, Uramoto, Hanagiri: "Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC." in: Anticancer research, Vol. 30, Issue 9, pp. 3273-8, 2010 (PubMed).
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, 2010 (PubMed).
Liang, Zheng, Xiao, Li, Cheng, Wang: "Dysadherin expression in gastrointestinal stromal tumors (GISTs)." in: Pathology, research and practice, Vol. 205, Issue 7, pp. 445-50, 2009 (PubMed).
Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, 2009 (PubMed).
Batistatou, Charalabopoulos, Nakanishi, Vagianos, Hirohashi, Agnantis, Scopa: "Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin." in: Endocrine pathology, Vol. 19, Issue 3, pp. 197-202, 2008 (PubMed).